ClariVest Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,908
| Closed | -$2.43M | – | 796 |
|
|
2021
Q3 | $2.43M | Sell |
26,908
-6,003
| -18% | -$541K | 0.08% | 217 |
|
|
2021
Q2 | $3.14M | Sell |
32,911
-181
| -0.5% | -$17.3K | 0.1% | 177 |
|
|
2021
Q1 | $3.77M | Buy |
33,092
+2,727
| +9% | +$311K | 0.13% | 146 |
|
|
2020
Q4 | $4.2M | Sell |
30,365
-8,823
| -23% | -$1.22M | 0.14% | 124 |
|
|
2020
Q3 | $3.22M | Buy |
+39,188
| New | +$3.22M | 0.11% | 153 |
|
|
2016
Q3 | – | Sell |
-12,552
| Closed | -$613K | – | 739 |
|
|
2016
Q2 | $613K | Buy |
12,552
+1,700
| +16% | +$83K | 0.02% | 350 |
|
|
2016
Q1 | $687K | Buy |
10,852
+6,391
| +143% | +$405K | 0.02% | 328 |
|
|
2015
Q4 | $501K | Sell |
4,461
-106
| -2% | -$11.9K | 0.01% | 347 |
|
|
2015
Q3 | $440K | Buy |
+4,567
| New | +$440K | 0.01% | 338 |
|